Pfizer is seeking to boost its coverage of research into orphan conditions with the creation of a new unit focused …

OgilvyHealthPR has appointed Ben Fisher as associate director. He joins the agency from Porter Novelli and has ten years experience …
Pharma manufacturing company Novasep has appointed Stephen Stefano to head up its US business and Patrick Glasser to lead its …
Contract services company Patheon swung back into profit in the second quarter of the year, helped by a weak dollar, …

Novo Nordisk has been given a limited approval for its new type II diabetes treatment in draft guidance issued by …
Pfizer and Bristol-Myers Squibb’s atrial fibrillation treatment apixaban has performed so well in a phase III trial that it has …

Janssen-Cilag has launched a new UK campaign to raise awareness of ADHD among teenagers, their parents and teachers. The campaign’s …
Boehringer Ingelheim has given a robust rebuttal to a Lancet report implicating its hypertension drug Micardis (telmisartan) in scares about …
Leading pharma companies have come together for a major new research collaboration aimed at improving clinical trials for Alzheimer’s, Parkinson’s, …

Packaging and clinical supply services company Brecon Pharmaceuticals has appointed Dr Herbert Pomper to the newly created role of associate …
Gareth Thomas has joined UK online medical professional network Doctors.net.uk as international development director.
The UK has a strong history of innovation in medicines and it is vital to the economy that this continues …
Researchers at GlaxoSmithKline and two UK universities are working on a technology that could allow active pharmaceutical ingredients to be …

NHS Direct is piloting online decision aids to help patients suffering from osteoporosis or prostate cancer make informed healthcare choices. …
Janssen-Cilag has called in Virgo Health and Open Road to help boost the fortunes of its injectable antipsychotic drug Risperdal …

GlaxoSmithKline has acquired a leading Argentine pharma firm Laboratorios Phoenix in a move to make further inroads into Latin America. …
Closure of a manufacturing facility in France operated by Bristol-Myers Squibb could lead to shortages of an important treatment for …
Novartis’ oral MS therapy Gilenia has been boosted by an FDA committee’s unanimous recommendation for its approval. The drug is …
NDA, the leading European regulatory affairs consulting group, appoints Dr Panos Tsintis to its expanding panel of experts – the …
Glenn Kerkhof, Chiltern CEO, commented, “A key benefit of Collaborative Technologies is the immediate access to current study information which …